C19H17F6N7O
473.4 g/mol
APIDanger
Enasidenib
CAS1446502-11-9EC107-597-8
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Enasidenib is a 1,3,5-triazine compound that acts as an inhibitor of isocitrate dehydrogenase 2 (IDH2). It is used as an active pharmaceutical ingredient in the manufacturing of medicines for certain hematologic malignancies.
inhibitor of isocitrate dehydrogenase 2 (IDH2)
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1446502-11-9
Related Compounds
StrongSame Parent
Enasidenib mesylate
CAS1650550-25-6
pharmaceutical raw material
ReferenceSame Category
Acoramidis
CAS1446711-81-4
pharmaceutical raw material
ReferenceSame Category
Olmesartan
CAS144689-24-7
pharmaceutical raw material
ReferenceSame Category
Olmesartan medoxomil
CAS144689-63-4
pharmaceutical raw material
ReferenceSame Category
Telmisartan
CAS144701-48-4
pharmaceutical raw material
Safety Reference
Danger
H360May damage fertility or the unborn child
H373May cause damage to organs through prolonged or repeated exposure
H413May cause long lasting harmful effects to aquatic life
Identifiers
IUPAC Name
2-methyl-1-[[4-[6-(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol
InChIKey
DYLUUSLLRIQKOE-UHFFFAOYSA-N
SMILES
CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O
Synonyms (12)
- IDHIFA
- Enasidenib (USAN/INN)
- AG-221 (Enasidenib)
- CC-90007 Free Base
- Enasidenib
- Enasidenib; AG-221
- enasidenibum